Another important finding of our study is the potential influence of prolonged exposure to high levels of leptin on the action of lenvatinib, a PKI approved for the treatment of radioiodine refractory thyroid cancer [21] which has also been shown to block the proliferation of some thyroid cancer cell lines in vitro [22]. The gene discussed is LEP; the disease is thyroid gland carcinoma.